Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Sleep Med ; 16(8): 1006-10, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26116464

RESUMEN

BACKGROUND: Restless legs syndrome (RLS) is associated with cerebrovascular risk factors, but its possible association with cerebrovascular disease has yielded conflicting results. OBJECTIVE: This was a case-control, in-hospital study to evaluate the association between RLS and acute stroke or transient ischemic attack (TIA). METHODS: We evaluated patients hospitalized with acute stroke/TIA and an age and gender 2:1 frequency-matched control group, for the presence of RLS. RESULTS: Twenty-two of 149 patients (15%) and 10 of 298 controls (3%) suffered from RLS (p <0.0001). A multivariate logistic regression model employing cerebrovascular risk factors as predictors, that is, hypertension, hyperlipidemia, diabetes, and body mass index (BMI), determined that stroke/TIA was significantly associated with RLS with odds ratio for RLS among patients with stroke/TIA versus controls of 7.60 (95% confidence interval (CI): 2.07-27.87; p = 0.002). Another multivariate logistic regression model adjusting for possible RLS risk factors, that is, hypertension, hyperlipidemia, diabetes, BMI, anemia, and reduced renal function, determined that stroke/TIA was significantly associated with RLS with odds ratio of 6.85 (95% CI: 6.85-1.79; p = 0.005). Stepwise logistic regression with hypertension, hyperlipidemia, diabetes, BMI, anemia, and reduced renal function as potential predictors revealed that only stroke/TIA predicted RLS with similar odds ratio to the RLS-based multivariate model of 6.54 (95% CI: 2.63-16.27; p <0.0001). CONCLUSIONS: Examining stroke patients while in hospital allowed us to conclude that RLS and acute stroke/TIA are significantly associated. However, the cross-sectional design did not allow for the determination of a causative relationship between the two.


Asunto(s)
Síndrome de las Piernas Inquietas/complicaciones , Accidente Cerebrovascular/complicaciones , Estudios de Casos y Controles , Femenino , Humanos , Entrevistas como Asunto , Ataque Isquémico Transitorio/complicaciones , Modelos Logísticos , Masculino , Persona de Mediana Edad , Factores de Riesgo
2.
Eur J Neurol ; 20(10): 1375-82, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23701659

RESUMEN

BACKGROUND AND PURPOSE: Reduced endogenous pain inhibition, as part of the degenerative process, is presumed to be the mechanism underlying the common presence of pain in patients with Parkinson's disease (PD). The present study aimed to assess an endogenous pain inhibitory system in PD using the conditioned pain modulation paradigm. METHODS: Twenty-six predominantly unilateral PD patients and 19 controls underwent psychophysical pain assessment before and after patients' morning dopaminergic medication. RESULTS: An unexpected increase in several parameters of pain perception for PD patients was found after dopaminergic medication (e.g. for 49°C noxious heat stimulation an increase from 70.6 ± 4.0 to 77.6 ± 4.0 on the numerical pain scale, P < 0.001). This increase was seen in patients with predominantly left-sided PD, regardless of the stimulated side (for 49°C noxious heat stimulation, predominantly left-sided PD patients, pain perception increased from 73.5 ± 6.8 to 85.0 ± 6.8, P < 0.001, whereas predominantly right-sided PD patients did not show a significant increase, 68.3 ± 6.8 to 70.4 ± 6.5, P = 0.777). Baseline efficiency of conditioned pain modulation inversely correlated with age at disease onset (r = -0.522; P = 0.009) and disease severity (Unified PD Rating Scale, r = 0.447; P = 0.032) but did not differ between patients and controls. CONCLUSIONS: Increased sensory response causing hyperalgesia occurs after dopaminergic medication in patients with predominantly left-sided PD.


Asunto(s)
Antiparkinsonianos/efectos adversos , Lateralidad Funcional/fisiología , Hiperalgesia/inducido químicamente , Percepción del Dolor/efectos de los fármacos , Enfermedad de Parkinson/fisiopatología , Anciano , Femenino , Humanos , Hiperalgesia/fisiopatología , Levodopa/efectos adversos , Masculino , Persona de Mediana Edad , Dolor , Dimensión del Dolor , Percepción del Dolor/fisiología , Umbral del Dolor/efectos de los fármacos , Umbral del Dolor/fisiología , Enfermedad de Parkinson/tratamiento farmacológico , Psicofísica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA